泓博医药(301230.SZ)：帕拉米韦是公司的商业化品种之一
Pharma Resources (Shanghai) Pharma Resources (Shanghai) (SZ:301230) Ge Long Hui·2025-12-09 01:13

Core Viewpoint - Hongbo Pharmaceutical (301230.SZ) has indicated that Palivizumab is one of its commercialized products, suitable for treating influenza viruses causing common influenza, type A influenza, or type B influenza [1] Group 1 - Hongbo Pharmaceutical's product Palivizumab is aimed at addressing various types of influenza viruses [1]